Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
This quick comparison explains why price indices and total return indices diverge, focusing on dividends and reinvestment effects.
28,657 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Stocks edge higher pre-market as oil nears $100 a barrel, lifting energy names while weighing inflation and growth pr...
Investors are watching after reports that Mojtaba Khamenei could become Iran’s next supreme leader. The potential mov...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...
A lithium-focused startup has joined the unicorn club after a surge in demand for EV batteries. The move signals a br...
Two North American midstream giants posted earnings that point to divergent paths for dividend investors in 2026. ENB...
Oracle stock faces a pivotal moment as management doubles down on AI infrastructure while financing plans raise dilut...
Analysts issue refreshed Tuesday notes on a slate of large-cap names, signaling where investors may push for upside a...
A high dividend yield can catch the eye. This guide breaks down whether yielding 6.5% on Altria stock is a solid long...
Analysts issue fresh calls on Block, CrowdStrike, Fortinet, and other tech names as markets digest rising yields and ...
Gold prices surged past $5,100 per ounce as tariff jitters pushing gold heightened safe-haven demand, with silver als...
SpaceX is preparing the largest IPO in history, valued near $1.77 trillion, as Wall Street debates whether AI-driven ...